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Summary 
Irritable bowel syndrome (IBS) is the most common gastro-
intestinal disorder, of largely unknown etiology and patho-
biology. There is growing evidence regarding the genetic con-
tribution in IBS, however the precise etiology of IBS is still 
unknown. Recently, it has been proposed that several genetic 
markers are associated with some aspect of IBS. Neuropeptide S 
receptor 1 (NPSR1), the receptor for neuropeptide S (NPS), is 
expressed on the intestinal epithelium, and is involved in in-
flammation, anxiety, and nociception. NPSR1 gene was recently 
found to be genetically associated with inflammatory bowel dis-
ease and asthma.
1,2 The author wanted to determine whether 
NPS induces expression of gastrointestinal (GI) neuropeptides; 
and to associate NPSR1 single nucleotide polymorphisms 
(SNPs) with symptom phenotype and GI functions in health and 
functional GI disorders (FGID).
The author undertook the present study in vitro and in vivo 
model together. First, the effect of NPS on messenger RNA ex-
pression of neuropeptides was assessed in NPSR1-tranfected 
HEK293 cells. Second, 17 NPSR1 polymorphisms were com-
pared between 466 FGID patients and 233 healthy controls. They 
showed that NPS-NPSR1 signaling induced increased ex-
pressions of cholecystokinin, vasoactive intestinal peptide, peptide 
YY, and somatostatin. There were no significant associations with 
phenotypes of FGID symptoms. However, there were several 
NPSR1 SNPs associated with individual motor or sensory func-
tions; the associations of SNPs rs2609234, rs6972158, and 
rs1379928 with colonic transit rate, while the rs1379928 poly-
morphism was also associated with pain, gas, and urgency sensory 
ratings at 36 mm Hg distention. The author concluded that the ex-
pression of several neuropeptides is induced upon NPS-NPSR1 
signaling and NPSR1 variants are associated with colonic transit in 
FGID. NPSR1 Polymorphisms in FGID
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Comment
IBS is a multifactorial disorder, and several patholphysio-
logical mechanisms have been proposed, including altered bowel 
motility, visceral hypersensitivity, psychosocial factors, imbalance 
in neurotransmitters, and infections.
3 Familial aggregation and 
twin studies suggest that genetic factors are thought to have a role 
in the manifestation of functional dyspepsia and IBS.
4-10 Recent 
studies have noticed the importance of polymorphisms in the pro-
moter region of the serotonin reuptake transporter gene, G-pro-
tein, cholecystokinin receptor, and cytokines such as IL-10.
11,12
NPS is a recently identified bioactive 20 amino acid peptide 
whose primary sequence is highly conserved in different 
species.
13 NPS selectively binds and activates an orphan G-pro-
tein coupled receptor, named NPSR1.
13 The biological function 
of the NPSR1-NPS system in the gut is still poorly understood. 
Previous studies have reported NPSR1 expression in epithelial 
cells of several organs and tissues, and an increase of this ex-
pression during inflammations, such as IBS and asthma.
1,2 Thus, 
it may conceivably be associated with IBS given the increasing 
evidences of association of minor inflammation or prior infection 
with IBS. Recently, inhibition of distal colonic transit has been 
shown in mice upon intracerebroventricular administrations of 
NPS.
14
In this study, the expression of several neuropeptides 
(cholecystokinin, vasoactive intestinal peptide, peptide YY, and 
somatostatin) involved in the control of physiological motor and 
sensory functions in gastrointestinal tract increase upon 
NPS-NPSR1 signaling in an in vitro model. These finding sug-
gest that genetic alterations affecting NPSR1 expression might 
result in excessive or diminished neuropeptide inductions leading 
to perturbed gut function and possibly FGID. In these aspects, 
the authors have also studied 17 NPSR1 SNPs in an ethnically 
homogeneous group of 466 FGID patients with Rome II-pos-
itive criteria and 233 healthy controls from one geographical re-
gion of the United States. At present, most studies that inves-
tigated the genetic factors associated with FGID have been car-
ried out in patients with IBS. Although patients with functional 
dyspepsia were included in this study, main population of FGID 
was IBS patients occupying about 90%. The author failed to 
demonstrate significant associations of NPSR1 genotypes with 
symptom phenotypes of FGIDs. Meanwhile, intermediate phe-
notypes related to motor or sensory function were associated with 
3  NPSR1 SNPs (rs2609234, rs6972158, and rs1379928). 
Although the impacts of these SNPs on colonic transit rate were 
relatively weak with 10-16% accelerations of GC (geometric cen-
ter) 24/48 hours, these finding suggest that these polymorphisms 
could be related to diarrhea-predominant IBS. In addition, the 
rs1379928 polymorphism was also associated with increases of 
pain, gas, and urgency sensory ratings at 36 mmHg distention to 
around 9.9-22.5%. However, in electrophoretic mobility shift as-
says on 3 different cell lines, the author failed to demonstrate dif-
ferent bindings of nuclear proteins to DNA sequences according 
to rs1379928 alleles which affect both the colorectal motor and 
sensory function. Therefore further studies are needed to assess 
whether this SNP is truly functionally relevant. Their results pro-
vide evidences for involvement of NPSR1 in the genetic suscepti-
bility to intermediate phenotypes of gastrointestinal function and 
represent at least one potential mechanism to explain the genetic 
associations with IBS.
Main focus of this study is not on symptom phenotypes but 
rather on physiological phenotypes, thus, direct clinical relevance 
is unclear. However, these are also the strengths of the study be-
cause intermediate phenotypes could be more clearly defined and 
measured than symptom phenotype. In conclusion, this study 
provides the first evidence of an association of NPSR1 poly-
morphisms with gastrointestinal motor and sensory functions that 
are relevant to IBS. Replication studies will be important to con-
firm these findings in independent populations. Further analyses 
of NPSR1 function are encouraged to elucidate its role in 
FGIDs and the potential associations with epithelial barrier func-
tions, inflammation, sensation, transit, and satiation in health and 
disease. 
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